2018
DOI: 10.3390/v10100545
|View full text |Cite
|
Sign up to set email alerts
|

Epidemiology and Elimination of HCV-Related Liver Disease

Abstract: Hepatitis C virus (HCV) infection, defined by active carriage of HCV RNA, affects nearly 1.0% of the worldwide population. The main risk factors include unsafe injection drug use and iatrogenic infections. Chronic HCV infection can promote liver damage, cirrhosis and hepatocellular carcinoma (HCC) in affected individuals. The advent of new second-generation, direct-acting antiviral (DAA) agents allow a virological cure in more than 90% of treated patients, and therefore prevent HCV-related complications. Recen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
35
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
5
4
1

Relationship

0
10

Authors

Journals

citations
Cited by 54 publications
(38 citation statements)
references
References 104 publications
(143 reference statements)
3
35
0
Order By: Relevance
“…24 In addition, the rate of treated patients with HCV can be very low in the community can. 25 It is thought that HCV infection rate decreases with antiviral treatments, but more time is required for decreasing HCC rates. 26 The most striking feature of present study was the significant increase in NASH among the causes of HCC 2013 and later.…”
Section: Resultsmentioning
confidence: 99%
“…24 In addition, the rate of treated patients with HCV can be very low in the community can. 25 It is thought that HCV infection rate decreases with antiviral treatments, but more time is required for decreasing HCC rates. 26 The most striking feature of present study was the significant increase in NASH among the causes of HCC 2013 and later.…”
Section: Resultsmentioning
confidence: 99%
“…The advent of DAA agents in patients with HCV allows a virological cure in more than 95% of treated patients, and therefore high rates of decreases of HCV-related complications are also expected in the real-world clinical practice [41,42]. The mechanism for the decreased serum Zn level in HCV-related LC is presumed to involve the non-structural (NS) proteins 3 (NS3, Zn-containing enzyme) and NS5A (Zn metalloprotein) of HCV, but the serum Zn concentration itself may not be affected by the HCV genotype and HCV viral load [43][44][45][46].…”
Section: Discussionmentioning
confidence: 99%
“…Drug injection is the most important risk factor for the acquisition of HCV infection in large urban centers, especially in young individuals. In addition, the high prevalence in satellite cities may be explained by the large influx of migrants 15,24,28,29 .…”
Section: Discussionmentioning
confidence: 99%